![No accumulation of a prophylactic dose of nadroparin in moderate renal insufficiency. | Semantic Scholar No accumulation of a prophylactic dose of nadroparin in moderate renal insufficiency. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/593fb5c173db06459b6e8c29abee562f42403c81/3-Table1-1.png)
No accumulation of a prophylactic dose of nadroparin in moderate renal insufficiency. | Semantic Scholar
![Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study - Thrombosis Research Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study - Thrombosis Research](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/976a2aca-16ed-453e-861c-3370789914b4/gr1_lrg.jpg)
Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study - Thrombosis Research
Article: Anticoagulation with dalteparin and nadroparin in nocturnal haemodialysis (full text) - July 2015 - NJM
![Effect of Nadroparin, a Low-Molecular-Weight Heparin, on Clinical and Angiographic Restenosis After Coronary Balloon Angioplasty | Circulation Effect of Nadroparin, a Low-Molecular-Weight Heparin, on Clinical and Angiographic Restenosis After Coronary Balloon Angioplasty | Circulation](https://www.ahajournals.org/cms/asset/bec6489d-9fcd-44e1-b19c-bd9034375502/hc2471093001.jpg)
Effect of Nadroparin, a Low-Molecular-Weight Heparin, on Clinical and Angiographic Restenosis After Coronary Balloon Angioplasty | Circulation
![No accumulation of a prophylactic dose of nadroparin in moderate renal insufficiency. | Semantic Scholar No accumulation of a prophylactic dose of nadroparin in moderate renal insufficiency. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/593fb5c173db06459b6e8c29abee562f42403c81/3-Table2-1.png)
No accumulation of a prophylactic dose of nadroparin in moderate renal insufficiency. | Semantic Scholar
Article: Anticoagulation with dalteparin and nadroparin in nocturnal haemodialysis (full text) - July 2015 - NJM
Article: No accumulation of a prophylactic dose of nadroparin in moderate renal insufficiency (full text) - October 2015 - NJM
![Nadroparin in the prophylaxis and treatment of thromboembolic complications in cancer patients | Semantic Scholar Nadroparin in the prophylaxis and treatment of thromboembolic complications in cancer patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cdec8c8b5e9f4b8aed1d189aa461ffa62991570a/7-Table5-1.png)
Nadroparin in the prophylaxis and treatment of thromboembolic complications in cancer patients | Semantic Scholar
![Dose linearity. The correlation between anti-Xa activity and the dose... | Download Scientific Diagram Dose linearity. The correlation between anti-Xa activity and the dose... | Download Scientific Diagram](https://www.researchgate.net/publication/322935780/figure/fig2/AS:962653824499739@1606525965817/Dose-linearity-The-correlation-between-anti-Xa-activity-and-the-dose-of-nadroparin.gif)
Dose linearity. The correlation between anti-Xa activity and the dose... | Download Scientific Diagram
![Mean anti-Xa activity per dosage group and treatment duration. Vertical... | Download Scientific Diagram Mean anti-Xa activity per dosage group and treatment duration. Vertical... | Download Scientific Diagram](https://www.researchgate.net/profile/Carlo-Gaillard/publication/259970657/figure/fig1/AS:297107060740097@1447847252078/Guideline_Q320.jpg)
Mean anti-Xa activity per dosage group and treatment duration. Vertical... | Download Scientific Diagram
![Nadroparin in the prophylaxis and treatment of thromboembolic complications in cancer patients | Semantic Scholar Nadroparin in the prophylaxis and treatment of thromboembolic complications in cancer patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cdec8c8b5e9f4b8aed1d189aa461ffa62991570a/6-Table4-1.png)